The Company, Avon Lifesciences was incorporated on August 03 1993, as Avon Organics Limited in Solapur. It got testament of initiation of business on July 5, 1994, advanced by Mr. P.R. Agarwal, Mr. Rajesh Agarwal and Dr. G.S. Sidhu. The Company changed its name from Avon Organics Ltd to Avon Lifesciences Ltd later in 2015.

Avon Lifesciences Solapur proposes to produce Diketene and subordinates – Mono Methyl Acetoacetamide (MMA) and Methyl Aceto Acetate (MAA). Diketene is simply the mother chemical and isn’t sold. The Company has gone into a Tripartite Agreement dated 12th October 1994, for which the Department of Industrial Development, Secretariat of Industrial Approvals, Ministry of Industry, has given consent vide their letter FC.II No:90(93)/4/ILF/93 dated April second, 1993, with Shanghai Machinery and Equipment Import and Export Corporation (SMEC), for the benefit of Shanghai Peng Pu Chemical Works (SPCW) for innovation exchange and with Xytel Technologies Partnership, U S A for the co-appointment and exchange of innovation (between the Company and SMEC).

Ajit Kamath and Manoj Jain are the Avon Lifesciences Directors. The Company on August 12, 2015 has apportioned 1,05,00,000 (One Crore Five Lacs) Warrants convertible into break even with number of value offers of Rs.10/ – each at an issue cost of Rs.26/ – each (counting premium of Rs.16/ – each) on particular premise to non promoters, as per Exceptional Resolution went through Postal Ballot and in consistence with different laws appropriate for such Preferential issue. According to the Special Resolution went through Postal Ballot and the endorsement got from the Ministry of Corporate Affairs through the Recorder of Companies. The Management trusts that the business potential and basics of the Company stays hearty. The Management is industriously seeking after each chance to recuperate from the misfortunes brought about and is certain of better circumstances ahead.

The organization has marked two long term send out contracts to supply settled amounts of Pseudoephedrine and is in converses with a couple of more MNC’s for long haul contracts amid the year 2001-02. The organization’s profile tech division is seeking after USFD endorsement which will empower it to go into controlled markets.

Labels : Avon lifesciences, Avon life sciences directors, Avon lifesciences latest news, Avon lifesciences solapur, Avon Lifesciences products, Manoj Jain Avon lifesciences, Ajit Kamath, Ajit Kamath Avon lifesciences, Avon lifesciences Mumbai, Avon lifesciences ltd website, Avon lifesciences owner